These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29797573)

  • 1. Mcl-1 targeting could be an intriguing perspective to cure cancer.
    De Blasio A; Vento R; Di Fiore R
    J Cell Physiol; 2018 Nov; 233(11):8482-8498. PubMed ID: 29797573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.
    Bae J; Leo CP; Hsu SY; Hsueh AJ
    J Biol Chem; 2000 Aug; 275(33):25255-61. PubMed ID: 10837489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
    Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
    Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy.
    Mittal P; Singh S; Sinha R; Shrivastava A; Singh A; Singh IK
    Int J Biol Macromol; 2021 Sep; 187():999-1018. PubMed ID: 34339789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
    Trivigno D; Essmann F; Huber SM; Rudner J
    Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair.
    Kojima S; Hyakutake A; Koshikawa N; Nakagawara A; Takenaga K
    Biochem Biophys Res Commun; 2010 Jan; 391(1):492-7. PubMed ID: 19919825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Mcl-1 promotes senescence in cancer cells: implications for preventing tumor growth and chemotherapy resistance.
    Bolesta E; Pfannenstiel LW; Demelash A; Lesniewski ML; Tobin M; Schlanger SE; Nallar SC; Papadimitriou JC; Kalvakolanu DV; Gastman BR
    Mol Cell Biol; 2012 May; 32(10):1879-92. PubMed ID: 22451485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers.
    Palve V; Mallick S; Ghaisas G; Kannan S; Teni T
    PLoS One; 2014; 9(11):e111927. PubMed ID: 25409302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy.
    Senichkin VV; Streletskaia AY; Zhivotovsky B; Kopeina GS
    Trends Cell Biol; 2019 Jul; 29(7):549-562. PubMed ID: 31030977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
    Modugno M; Banfi P; Gasparri F; Borzilleri R; Carter P; Cornelius L; Gottardis M; Lee V; Mapelli C; Naglich JG; Tebben A; Vite G; Pastori W; Albanese C; Corti E; Ballinari D; Galvani A
    Exp Cell Res; 2015 Mar; 332(2):267-77. PubMed ID: 25486070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
    Tanaka T; Kikuchi N; Goto K; Iino M
    Apoptosis; 2016 May; 21(5):594-608. PubMed ID: 26892009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming.
    Conage-Pough JE; Boise LH
    FEBS J; 2018 Jul; 285(14):2626-2640. PubMed ID: 29775995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence.
    Demelash A; Pfannenstiel LW; Liu L; Gastman BR
    Oncotarget; 2017 Apr; 8(17):28154-28168. PubMed ID: 28423654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
    Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
    Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis.
    Bae J; Donigian JR; Hsueh AJ
    J Biol Chem; 2003 Feb; 278(7):5195-204. PubMed ID: 12475993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
    Vallet S; Fan F; Malvestiti S; Pecherstorfer M; Sattler M; Schneeweiss A; Schulze-Bergkamen H; Opferman JT; Cardone MH; Jäger D; Podar K
    Breast Cancer Res Treat; 2019 Feb; 173(3):585-596. PubMed ID: 30374681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delving deeper: MCL-1's contributions to normal and cancer biology.
    Perciavalle RM; Opferman JT
    Trends Cell Biol; 2013 Jan; 23(1):22-9. PubMed ID: 23026029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain.
    Demelash A; Pfannenstiel LW; Tannenbaum CS; Li X; Kalady MF; DeVecchio J; Gastman BR
    J Biol Chem; 2015 Sep; 290(36):21962-75. PubMed ID: 26205817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mcl-1 as a "barrier" in cancer treatment: Can we target it now?
    Pervushin NV; Senichkin VV; Zhivotovsky B; Kopeina GS
    Int Rev Cell Mol Biol; 2020; 351():23-55. PubMed ID: 32247581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of antiapoptotic MCL-1.
    Lee S; Wales TE; Escudero S; Cohen DT; Luccarelli J; Gallagher CG; Cohen NA; Huhn AJ; Bird GH; Engen JR; Walensky LD
    Nat Struct Mol Biol; 2016 Jun; 23(6):600-7. PubMed ID: 27159560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.